ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Order Full text via Infotrieve
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Potena, A
Right arrow Articles by Ciaccia, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Potena, A
Right arrow Articles by Ciaccia, A
Eur Respir J 1990; 3: 548-553
Copyright © ERS Journals Ltd 1990


Original Articles

Increased bronchial responsiveness in primary and secondary Sjogren's syndrome

A Potena, R La Corte, LM Fabbri, A Papi, F Trotta, and A Ciaccia

We examined one group of 33 patients with primary Sjogren's syndrome, one group of 17 patients with secondary Sjogren's syndrome, i.e. associated with other connective tissue diseases, and one group of 14 patients with connective tissue diseases but without Sjogren's syndrome. In each patient we obtained chest radiographs and measured lung volumes, carbon monoxide diffusing capacity and airway responsiveness to methacholine. We observed no difference in chest radiograph abnormalities, in lung volumes and in carbon monoxide diffusing capacity among the three groups. However, we found a slight but significant increase of bronchial responsiveness in patients with primary and secondary Sjogren's syndrome compared with patients with connective tissue disorders but without Sjogren's syndrome. Thus PD20FEV1 methacholine was 1.07 mg (1.2) (geometric mean and GSEM) in primary Sjogren's syndrome, 0.91 mg (1.4) in secondary Sjogren's syndrome (NS), and 2.24 mg (1.09) in patients with connective tissue diseases but without Sjogren's syndrome (t = 2.59 and t = 2.8, both p less than 0.05, vs primary and secondary Sjogren's syndrome, respectively). These results show that some patients with Sjogren's syndrome have mild bronchial hyperresponsiveness, which may be related to the specific airway abnormalities of this disease.


This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. McGrath-Morrow, B. Laube, S.-C. Tzou, C. Cho, J. Cleary, H. Kimura, N. R. Rose, and P. Caturegli
IL-12 overexpression in mice as a model for Sjogren lung disease
Am J Physiol Lung Cell Mol Physiol, October 1, 2006; 291(4): L837 - L846.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
R Polosa, S Rorke, and S T Holgate
Evolving concepts on the value of adenosine hyperresponsiveness in asthma and chronic obstructive pulmonary disease
Thorax, July 1, 2002; 57(7): 649 - 654.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
R. S. Harris and E. J. Mark
Case 17-2001- A 42-Year-Old Man with Multiple Pulmonary Cysts and Recurrent Respiratory Infections
N. Engl. J. Med., May 31, 2001; 344(22): 1701 - 1708.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. A. PAPIRIS, M. SAETTA, G. TURATO, R. LA CORTE, L. TREVISANI, C. E. MAPP, P. MAESTRELLI, L. M. FABBRI, and A. POTENA
CD4-Positive T-Lymphocytes Infiltrate the Bronchial Mucosa of Patients with Sjogren's Syndrome
Am. J. Respir. Crit. Care Med., July 1, 1997; 156(2): 637 - 641.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1990 by the European Respiratory Society.